You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 21, December 7, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Immunization
 •Adverse Effects
 •Alert me on articles by topic

Vaccine Safety—Achieving the Proper Balance

Kathleen M. Neuzil, MD, MPH; Marie R. Griffin, MD, MPH

JAMA. 2005;294:2763-2765.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Influenza is an acute respiratory disease that causes illness in individuals of all ages. Influenza causes repeated infections throughout life, is highly communicable, and is responsible for annual epidemics of varying severity. While influenza leads to a self-limited respiratory disease in the majority of individuals, it is deadly in others. Influenza is the leading cause of vaccine-preventable hospitalizations and deaths in both children and adults in the United States.1-2 The seriousness of influenza in young children, older adults, and in persons of all ages with certain underlying medical conditions is the reason these individuals and their close contacts are targeted for influenza vaccination each year.2

Although hospitalization and death rates among healthy older children and adults are low, a substantial number of such persons miss work or school, visit a health care professional, or receive antibiotics for influenza-associated illnesses. In . . . [Full Text of this Article]

Author Affiliations: PATH (Program for Appropriate Technology in Health) and Department of Medicine, University of Washington, Seattle (Dr Neuzil); and Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tenn (Dr Griffin).


RELATED ARTICLE

Adverse Events Reported Following Live, Cold-Adapted, Intranasal Influenza Vaccine
Hector S. Izurieta, Penina Haber, Robert P. Wise, John Iskander, Douglas Pratt, ChrisAnna Mink, Soju Chang, M. Miles Braun, and Robert Ball
JAMA. 2005;294(21):2720-2725.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.